Driving forces of vancomycin-resistant E. faecium and E. faecalis blood-stream infections in children

Antimicrobial Resistance and Infection Control

Maria Cecilia Di Pentima¹  Shannon Chan³  Carol Briody⁴  Michelle Power⁴  Jobayer Hossain² 

[1] Infectious Diseases Division, Department of Pediatrics, Vanderbilt University, D-7235 Medical Center North, 1161 21st Avenue South, Nashville, Tennessee, USA

[2] Department of Food and Resource Economics, University of Delaware, Newark, Delaware, USA

[3] Department of Pediatrics, Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA

[4] Christiana Health Care System, Newark, USA

关键词: Bacteremia;    Vancomycin;    Enterococcus spp;    Enterococcus faecalis;    Enterococcus faecium;   

Others  :  1084079
DOI  :  10.1186/2047-2994-3-29

 received in 2014-02-27, accepted in 2014-08-18,  发布年份 2014

【 摘 要 】

Background

Rates of invasive vancomycin-resistant Enterococcus (VRE) in the USA remains on the rise. Efforts to control vancomycin use and nosocomial transmission have had limited success in halting the spread of this pathogen. The role of antibiotic exposure remains a topic of controversy. We evaluated the association between emergence of VRE-blood-stream infections (BSI), aggregate and individual-patient vancomycin- exposure, and clonal transmission of VRE at an academic pediatric tertiary care hospital.

Methods

E. faecium and E. faecalis isolates recovered from blood specimens from hospitalized children from 2003–2010 were retrieved from the microbiology database. Aggregate vancomycin use and individual-patient vancomycin exposure 6 months preceding each event of bacteremia were recorded. Pulse-field electrophoresis was performed on selected VRE isolates.

Results

Of 151 episodes of E. faecium and E. faecalis BSI among hospitalized children <18 years of age, 9% (14) were due to VRE. Of these, 5 (36%) were due to nosocomial transmission. Aggregate (r .19, P = 0.3) and individual-patient vancomycin-exposure (X² = .26; P = .87) were not associated with VRE-BSI. On bivariate analysis, OR for developing VRE-BSI among patients infected with clonal isolates was 36 (P < .0001). Infection control interventions, rather than antimicrobial stewardship interventions to decrease vancomycin use, proved to be effective in reducing the rates of VRE-BSI.

Conclusions

In our experience, VRE-BSI was associated with nosocomial transmission and was independent of aggregate and individual-patient vancomycin-exposure. Molecular epidemiology is a crucial tool to differentiate the role of nosocomial transmission and antibiotic exposure in the emergence of invasive VRE infections among hospitalized children.

【 授权许可】

   
2014 Di Pentima et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 4.

【 参考文献 】

• [1]Martone WJ: Spread of vancomycin-resistant enterococci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998, 19(8):539-545.
• [2]Duchon J, Graham Iii P, Della-Latta P, Whittier S, Carp D, Bateman D, Saiman L: Epidemiology of enterococci in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2008, 29(4):374-376.
• [3]Harbarth S, Cosgrove S, Carmeli Y: Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002, 46(6):1619-1628.
• [4]Zaas AK, Song X, Tucker P, Perl TM: Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002, 35(10):1139-1146.
• [5]Paterson DL, Muto CA, Ndirangu M, Linden PK, Potoski BA, Capitano B, Bonomo RA, Aron DC, Donskey CJ: Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens. Antimicrob Agents Chemother 2008, 52(2):465-469.
• [6]Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB: Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000, 343(26):1925-1932.
• [7]Derks EM, Dolan CV, Boomsma DI: Effects of censoring on parameter estimates and power in genetic modeling. Twin Res 2004, 7(6):659-669.
• [8]Zirakzadeh A, Gastineau DA, Mandrekar JN, Burke JP, Johnston PB, Patel R: Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008, 41(4):385-392.
• [9]Di Pentima MC, Chan S, Hossain J: Benefits of a pediatric antimicrobial stewardship program at a children's hospital. Pediatrics 2011, 128(6):1062-1070.
• [10]Di Pentima MC, Chan S: Impact of Antimicrobial Stewardship Program on vancomycin use in a Pediatric Teaching Hospital. Pediatr Infect Dis J 2010, 29(8):707-711.
• [11]Chow JW, Kuritza A, Shlaes DM, Green M, Sahm DF, Zervos MJ: Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 1993, 31(6):1609-1611.
• [12]Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33(9):2233-2239.
• [13]Di Pentima MC, Chan S, Hossain J: Impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital. Pediatr Infect Dis Jin Press
• [14]Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, Cronin M, Nasraway SA, Golan Y: Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2008, 29(8):709-715.